NCT07362160 Clear Orthodontic Expander Versus Hyrax
| NCT ID | NCT07362160 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Baghdad |
| Condition | Malocclusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-02-01 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be conducted to evaluate the effectiveness of a clear expander fabricated from 2-mm biocompatible polyethylene terephthalate glycol (PETG) thermoforming material integrated with an expansion screw in achieving dental and skeletal expansion in adolescent patients, compared with the conventional Hyrax expander.
Eligibility Criteria
Inclusion Criteria: 1. Patients' age at the start of treatment will range from 10-14 years. 2. Unstable unilateral or bilateral posterior crossbite due to maxillary constriction. 3. The first molars are fully erupted. 4. Good oral health free from caries and periodontal problems at the start of treatment. 5. Good general health. Exclusion Criteria: 1. Patients with obvious facial asymmetry. 2. Patients with orofacial cleft. 3. Patients with previous orthodontic treatment. 4. Patients with bad oral habits. 5. Patients with active periodontal disease.
Contact & Investigator
Yassir A Yassir, Ph.D. (UK)
STUDY CHAIR
University of Baghdad
Frequently Asked Questions
Who can join the NCT07362160 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 14 Years, studying Malocclusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07362160 currently recruiting?
Yes, NCT07362160 is actively recruiting participants. Contact the research team at noor.alkhawaja@codental.uobaghdad.edu.iq for enrollment information.
Where is the NCT07362160 trial being conducted?
This trial is being conducted at Baghdad, Iraq.
Who is sponsoring the NCT07362160 clinical trial?
NCT07362160 is sponsored by University of Baghdad. The principal investigator is Yassir A Yassir, Ph.D. (UK) at University of Baghdad. The trial plans to enroll 40 participants.